| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | Director | Common Stock, $0.01 par value | 35,646 | $6,209,533 | $174.20 | 09 May 2025 | Direct |
| ABBOTT LABORATORIES | Director | Common shares without par value | 40,798 | $5,411,854 | $132.65 | 25 Apr 2025 | Direct |
| AbbVie Inc. | Director | Stock Equivalent Units | 10,257 | $2,343,621 | $228.49 | 31 Dec 2025 | Direct |
| ABBOTT LABORATORIES | Director | Stock Equivalent Units | 10,409 | $1,304,143 | $125.29 | 31 Dec 2025 | Direct |
| Tricida, Inc. | Director | Common Stock | 0 | 23 Nov 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 31 Dec 2025 | 1 | +$7,768 | 4 | Director | 05 Jan 2026, 18:00 |
| ABBV | AbbVie Inc. | 31 Dec 2025 | 1 | +$7,769 | 4 | Director | 05 Jan 2026, 17:00 |
| ABBV | AbbVie Inc. | 30 Sep 2025 | 1 | +$7,641 | 4 | Director | 02 Oct 2025, 17:00 |
| ABT | ABBOTT LABORATORIES | 30 Sep 2025 | 1 | +$7,769 | 4 | Director | 02 Oct 2025, 16:34 |
| ABBV | AbbVie Inc. | 30 Jun 2025 | 1 | +$7,425 | 4 | Director | 02 Jul 2025, 17:00 |
| ABT | ABBOTT LABORATORIES | 30 Jun 2025 | 1 | +$7,753 | 4 | Director | 01 Jul 2025, 17:05 |
| ABBV | AbbVie Inc. | 09 May 2025 | 1 | $0 | 4 | Director | 13 May 2025, 17:05 |
| ABT | ABBOTT LABORATORIES | 25 Apr 2025 | 1 | $0 | 4 | Director | 29 Apr 2025, 17:03 |
| ABT | ABBOTT LABORATORIES | 31 Mar 2025 | 1 | +$7,826 | 4 | Director | 02 Apr 2025, 17:05 |
| ABBV | AbbVie Inc. | 31 Mar 2025 | 1 | +$7,333 | 4 | Director | 02 Apr 2025, 17:00 |
| ABT | ABBOTT LABORATORIES | 31 Dec 2024 | 1 | +$7,805 | 4 | Director | 03 Jan 2025, 17:02 |
| ABBV | AbbVie Inc. | 31 Dec 2024 | 1 | +$7,463 | 4 | Director | 03 Jan 2025, 17:00 |
| ABBV | AbbVie Inc. | 30 Sep 2024 | 1 | +$7,307 | 4 | Director | 02 Oct 2024, 17:00 |
| ABT | ABBOTT LABORATORIES | 30 Sep 2024 | 1 | +$7,867 | 4 | Director | 01 Oct 2024, 17:27 |
| ABT | ABBOTT LABORATORIES | 30 Jun 2024 | 1 | +$7,793 | 4 | Director | 02 Jul 2024, 16:22 |
| ABBV | AbbVie Inc. | 30 Jun 2024 | 1 | +$7,375 | 4 | Director | 02 Jul 2024, 16:18 |
| ABBV | AbbVie Inc. | 03 May 2024 | 1 | $0 | 4 | Director | 07 May 2024, 18:30 |
| ABT | ABBOTT LABORATORIES | 26 Apr 2024 | 1 | $0 | 4 | Director | 30 Apr 2024, 17:33 |
| ABT | ABBOTT LABORATORIES | 31 Mar 2024 | 1 | +$7,843 | 4 | Director | 02 Apr 2024, 18:32 |
| ABBV | AbbVie Inc. | 31 Mar 2024 | 1 | +$7,466 | 4 | Director | 02 Apr 2024, 17:00 |
| ABT | ABBOTT LABORATORIES | 31 Dec 2023 | 1 | +$7,815 | 4 | Director | 03 Jan 2024, 17:28 |
| ABBV | AbbVie Inc. | 31 Dec 2023 | 1 | +$7,439 | 4 | Director | 03 Jan 2024, 17:08 |
| ABT | ABBOTT LABORATORIES | 30 Sep 2023 | 1 | +$7,845 | 4 | Director | 03 Oct 2023, 18:45 |
| ABBV | AbbVie Inc. | 30 Sep 2023 | 1 | +$7,453 | 4 | Director | 03 Oct 2023, 17:00 |
| ABBV | AbbVie Inc. | 07 Sep 2023 | 1 | $0 | 4 | Director | 11 Sep 2023, 17:00 |
| ABBV | AbbVie Inc. | 30 Jun 2023 | 1 | +$7,410 | 4 | Director | 05 Jul 2023, 17:00 |
| ABT | ABBOTT LABORATORIES | 30 Jun 2023 | 1 | +$7,849 | 4 | Director | 05 Jul 2023, 11:54 |
| ABBV | AbbVie Inc. | 05 May 2023 | 1 | $0 | 4 | Director | 09 May 2023, 17:00 |
| ABT | ABBOTT LABORATORIES | 28 Apr 2023 | 1 | $0 | 4 | Director | 02 May 2023, 19:37 |
| ABT | ABBOTT LABORATORIES | 31 Mar 2023 | 1 | +$7,797 | 4 | Director | 04 Apr 2023, 19:25 |
| ABBV | AbbVie Inc. | 31 Mar 2023 | 1 | +$7,490 | 4 | Director | 04 Apr 2023, 17:00 |
| ABT | ABBOTT LABORATORIES | 31 Dec 2022 | 1 | +$7,795 | 4 | Director | 04 Jan 2023, 17:09 |
| ABBV | AbbVie Inc. | 31 Dec 2022 | 1 | +$7,434 | 4 | Director | 03 Jan 2023, 16:06 |
| /report/000159558522000093-alpern-robert-j-2022-11-23 | Tricida, Inc. | 23 Nov 2022 | 1 | -$27,695 | 4 | Director | 25 Nov 2022, 15:13 |
| /report/000159558522000091-alpern-robert-j-2022-11-21 | Tricida, Inc. | 21 Nov 2022 | 1 | -$6,344 | 4 | Director | 22 Nov 2022, 19:33 |
| ABT | ABBOTT LABORATORIES | 30 Sep 2022 | 1 | +$7,838 | 4 | Director | 04 Oct 2022, 17:21 |
| ABBV | AbbVie Inc. | 30 Sep 2022 | 1 | +$7,382 | 4 | Director | 04 Oct 2022, 17:02 |
| ABBV | AbbVie Inc. | 30 Jun 2022 | 1 | +$7,199 | 4 | Director | 05 Jul 2022, 17:25 |
| ABT | ABBOTT LABORATORIES | 30 Jun 2022 | 1 | +$7,823 | 4 | Director | 01 Jul 2022, 16:24 |
| /report/000159558522000057-alpern-robert-j-2022-06-15 | Tricida, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 16 Jun 2022, 16:34 |
| ABBV | AbbVie Inc. | 06 May 2022 | 1 | $0 | 4 | Director | 09 May 2022, 17:09 |
| ABT | ABBOTT LABORATORIES | 29 Apr 2022 | 1 | $0 | 4 | Director | 03 May 2022, 17:49 |
| ABBV | AbbVie Inc. | 31 Mar 2022 | 1 | +$7,133 | 4 | Director | 04 Apr 2022, 17:14 |
| ABT | ABBOTT LABORATORIES | 31 Mar 2022 | 1 | +$7,812 | 4 | Director | 01 Apr 2022, 17:21 |
| ABT | ABBOTT LABORATORIES | 31 Dec 2021 | 1 | +$7,741 | 4 | Director | 04 Jan 2022, 16:17 |
| ABBV | AbbVie Inc. | 31 Dec 2021 | 1 | +$7,176 | 4 | Director | 04 Jan 2022, 16:02 |
| ABT | ABBOTT LABORATORIES | 30 Sep 2021 | 1 | +$7,797 | 4 | Director | 04 Oct 2021, 17:27 |
| ABBV | AbbVie Inc. | 30 Sep 2021 | 1 | +$7,119 | 4 | Director | 04 Oct 2021, 17:04 |
| ABT | ABBOTT LABORATORIES | 30 Jun 2021 | 1 | +$7,767 | 4 | Director | 02 Jul 2021, 17:01 |
| ABBV | AbbVie Inc. | 30 Jun 2021 | 1 | +$7,098 | 4 | Director | 02 Jul 2021, 09:08 |
| /report/000159558521000076-alpern-robert-j-2021-06-10 | Tricida, Inc. | 10 Jun 2021 | 2 | $0 | 4 | Director | 11 Jun 2021, 17:07 |
| ABBV | AbbVie Inc. | 07 May 2021 | 1 | +$194,929 | 4 | Director | 11 May 2021, 17:05 |